HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevalence of dihydropteroate synthase genotypes before and after the introduction of combined antiretroviral therapy and their influence on the outcome of Pneumocystis pneumonia in HIV-1-infected patients.

Abstract
The objective of this study was to determine whether the prevalence of Pneumocystis jirovecii dihydropteroate synthase (DHPS) gene mutations has changed since the introduction of combined antiretroviral therapy (cART) and whether the mutations are associated with poor outcome in Spanish HIV-1-infected patients with Pneumocystis pneumonia (PcP). We studied 167 PcP episodes in HIV-1-infected patients diagnosed during the pre-cART (1989-1995) and cART (2001-2004) periods. Molecular genotyping of DHPS was successfully performed in 98 patients (43 pre-cART and 55 cART). Seventeen patients (17/98, 17%; 95% confidence interval [CI], 10-25%) had mutations in the DHPS gene: 14 patients (14/43, 33%; 95% CI, 19-49%) from the pre-cART period and 3 patients (3/55, 5.5%; 95% CI, 1.3-16%) from the cART period (P < 0.01). In the multivariate analysis, the pre-cART period, previous PcP prophylaxis with sulfa drugs, and homosexuality as an HIV risk factor were found to be associated with a higher risk of presenting DHPS mutations. Overall, 95% of patients were treated with trimethoprim and sulfamethoxazole (TMP-SMX). In-hospital mortality was similar in patients with (out) mutations (6% versus 11%, P = 0.84). DHPS gene mutations were more common during the pre-cART period and were associated with previous sulfa exposure and homosexuality. However, their presence did not worsen prognosis of PcP. The response to TMP-SMX with therapeutic doses was successful in most cases.
AuthorsMíriam J Alvarez-Martínez, José M Miró, Maria Eugenia Valls, Jordi Mas, Jorge Puig de la Bellacasa, Omar Sued, Manel Solé, Paula V Rivas, Elisa de Lazzari, Natividad Benito, Felipe García, Carlos Agustí, Paul E Wilson, José M Gatell, Maria Teresa Jiménez de Anta, Steven R Meshnick, Asunción Moreno
JournalDiagnostic microbiology and infectious disease (Diagn Microbiol Infect Dis) Vol. 68 Issue 1 Pg. 60-5 (Sep 2010) ISSN: 1879-0070 [Electronic] United States
PMID20727472 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-HIV Agents
  • Anti-Infective Agents
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Dihydropteroate Synthase
Topics
  • AIDS-Related Opportunistic Infections (microbiology, mortality)
  • Anti-HIV Agents (therapeutic use)
  • Anti-Infective Agents (therapeutic use)
  • Dihydropteroate Synthase (genetics)
  • Genotype
  • HIV Infections (complications, drug therapy, virology)
  • HIV-1 (drug effects)
  • Hospital Mortality
  • Humans
  • Mutation
  • Pneumocystis carinii (enzymology, genetics)
  • Pneumonia, Pneumocystis (drug therapy, microbiology, mortality)
  • Prevalence
  • Spain
  • Treatment Outcome
  • Trimethoprim, Sulfamethoxazole Drug Combination (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: